266
Views
24
CrossRef citations to date
0
Altmetric
Letter to the Editor

Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemia

, MD PhD &
Pages 1423-1425 | Received 09 Mar 2007, Accepted 23 Mar 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Roberto Mina, Mattia D’Agostino, Chiara Cerrato, Francesca Gay & Antonio Palumbo. (2017) Plasma cell leukemia: update on biology and therapy. Leukemia & Lymphoma 58:7, pages 1538-1547.
Read now
Antonino Neri, Katia Todoerti, Marta Lionetti, Vittorio Simeon, Marzia Barbieri, Filomena Nozza, Gabriella Vona, Alessandra Pompa, Luca Baldini & Pellegrino Musto. (2016) Primary plasma cell leukemia 2.0: advances in biology and clinical management. Expert Review of Hematology 9:11, pages 1063-1073.
Read now
Michaela Liedtke & Bruno C Medeiros. (2010) Plasma cell leukemia: concepts and management. Expert Review of Hematology 3:5, pages 543-549.
Read now

Articles from other publishers (21)

Matilda Ong’ondi & Elizabeth Kagotho. (2021) Plasma Cell Leukemia: A Review of 3 Cases Managed in Kenya. Case Reports in Hematology 2021, pages 1-6.
Crossref
Binod Dhakal, Sagar Patel, Saulius Girnius, Lohith Bachegowda, Raphael Fraser, Omar Davila, Abraham S. Kanate, Amer Assal, Amr Hanbali, Asad Bashey, Attaphol Pawarode, César O. Freytes, Cindy Lee, David Vesole, Robert Frank Cornell, Gerhard C. Hildebrandt, Hemant S. Murthy, Hillard M. Lazarus, Jan Cerny, Jean A. Yared, Jeffrey Schriber, Jesus Berdeja, Keith Stockerl-Goldstein, Kenneth Meehan, Leona Holmberg, Melhem Solh, Miguel Angel Diaz, Mohamed A. Kharfan-Dabaja, Nosha Farhadfar, Qaiser Bashir, Reinhold Munker, Richard F. Olsson, Robert P. Gale, Ruthlee-Lu Bayer, Sachiko Seo, Saurabh Chhabra, Shahrukh Hashmi, Sherif M. Badawy, Taiga Nishihori, Wilson Gonsalves, Yago Nieto, Yvonne Efebera, Shaji Kumar, Nina Shah, Muzaffar Qazilbash, Parameswaran Hari & Anita D’Souza. (2020) Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era. Leukemia 34:12, pages 3338-3347.
Crossref
Roberto Mina, Nisha S. Joseph, Jonathan L. Kaufman, Vikas A. Gupta, Leonard T. Heffner, Craig C. Hofmeister, Lawrence H. Boise, Madhav V. Dhodapkar, Charise Gleason, Ajay K. Nooka & Sagar Lonial. (2018) Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents. Cancer 125:3, pages 416-423.
Crossref
Artur Jurczyszyn, Jakub Radocha, Julio Davila, Mark A. Fiala, Alessandro Gozzetti, Norbert Grząśko, Paweł Robak, Iwona Hus, Anna Waszczuk-Gajda, Renata Guzicka-Kazimierczak, Erden Atilla, Giuseppe Mele, Waldemar Sawicki, David S. Jayabalan, Grzegorz Charliński, Agoston G. Szabo, Roman Hajek, Michel Delforge, Agnieszka Kopacz, Dorotea Fantl, Anders Waage, Irit Avivi, Marek Rodzaj, Xavier Leleu, Valentine Richez, Wanda Knopińska-Posłuszny, Anna Masternak, Andrew J. Yee, Agnieszka Barchnicka, Agnieszka Druzd-Sitek, Thomas Guerrero-Garcia, Jieqi Liu, David H. Vesole & Jorge J. Castillo. (2018) Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients. British Journal of Haematology 180:6, pages 831-839.
Crossref
Bruno RoyerStéphane MinvielleMomar DioufMurielle RousselLionel KarlinCyrille HulinBertrand ArnulfMargaret MacroSylvie CailleresAnnie BrionSabine BrechignacKarim BelhadjMarie Lorraine ChretienMarc WetterwaldCarine ChaleteixMourad TiabXavier LeleuLaurent FrenzelLaurent GarderetSylvain ChoquetJean Gabriel FuzibetCharles DauriacLuc-Matthieu FornekerLotfi BenboubkerThierry FaconPhilippe MoreauHervé Avet-LoiseauJean Pierre Marolleau. (2016) Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome. Journal of Clinical Oncology 34:18, pages 2125-2132.
Crossref
Pellegrino Musto, Vittorio Simeon, Katia Todoerti & Antonino Neri. (2016) Primary Plasma Cell Leukemia: Identity Card 2016. Current Treatment Options in Oncology 17:4.
Crossref
Shinobu Tamura, Asumi Koyama, Chieko Shiotani, Toshio Kurihara, Akinori Nishikawa, Yukiharu Okamoto & Tokuzo Fujimoto. (2014) Successful Bortezomib/dexamethasone Induction Therapy with Lenalidomide in an Elderly Patient with Primary Plasma Cell Leukemia Complicated by Renal Failure and Pulmonary Hypertension. Internal Medicine 53:11, pages 1171-1175.
Crossref
Taiga Nishihori, Sarah M. Abu Kar, Rachid Baz, Melissa Alsina, Jean-Luc Harousseau & Mohamed A. Kharfan-Dabaja. (2013) Therapeutic Advances in the Treatment of Primary Plasma Cell Leukemia: A Focus on Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 19:8, pages 1144-1151.
Crossref
C Fernández de Larrea, R A Kyle, B G M Durie, H Ludwig, S Usmani, D H Vesole, R Hajek, J F San Miguel, O Sezer, P Sonneveld, S K Kumar, A Mahindra, R Comenzo, A Palumbo, A Mazumber, K C Anderson, P G Richardson, A Z Badros, J Caers, M Cavo, X LeLeu, M A Dimopoulos, C S Chim, R Schots, A Noeul, D Fantl, U-H Mellqvist, O Landgren, A Chanan-Khan, P Moreau, R Fonseca, G Merlini, J J Lahuerta, J Bladé, R Z Orlowski & J J Shah. (2012) Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia 27:4, pages 780-791.
Crossref
Shuji Ueda, Masahiko Kubo, Noriko Matsuura, Hitomi Matsunaga, Seiko Kataoka, Tetsuo Maeda, Yoshiaki Inui, Sumio Kawata & Yuzuru Kanakura. (2013) Stringent Complete Remission of Primary Plasma Cell Leukemia with Reduced-dose Bortezomib, Lenalidomide and Dexamethasone: A Case Report and Review of the Literature. Internal Medicine 52:11, pages 1235-1238.
Crossref
Niels W. C. J. van de Donk, Henk M. Lokhorst, Kenneth C. Anderson & Paul G. Richardson. (2012) How I treat plasma cell leukemia. Blood 120:12, pages 2376-2389.
Crossref
Giampaolo TalamoNathan G. DolloffKamal SharmaJunjia Zhu & Jozef Malysz. (2017) Clinical Features and Outcomes of Plasma Cell Leukemia: A Single-Institution Experience in the era of Novel Agents. Rare Tumors 4:3, pages 123-126.
Crossref
Alessandro Gozzetti, Pellegrino Musto, Marzia Defina, Fiorella D'Auria, Giulia Papini, Teodora Steduto, Giovanni D'Arena & Monica Bocchia. (2012) Efficacy of bortezomib, lenalidomide and dexamethasone ( VRD ) in secondary plasma cell leukaemia . British Journal of Haematology 157:4, pages 497-498.
Crossref
Pellegrino Musto, Livio Pagano, Maria Teresa Petrucci, Fortunato Morabito, Tommaso Caravita, Francesco Di Raimondo, Luca Baldini, Patrizia Tosi, Sara Bringhen, Massimo Offidani, Paola Omede’, Antonino Neri, Fiorella D’Auria, Giovanni Battista Bochicchio, Michele Cavo, Mario Boccadoro & Antonio Palumbo. (2012) Primary plasma cell leukemia in the era of new drugs: Has something changed?. Critical Reviews in Oncology/Hematology 82:2, pages 141-149.
Crossref
Flavio Albarracin & Rafael Fonseca. (2011) Plasma cell leukemia. Blood Reviews 25:3, pages 107-112.
Crossref
Edward Libby, Dulcinea Candelaria‐Quintana, Hayan Moualla, Maryam Abdul‐Jaleel & Ian Rabinowitz. (2010) Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen. American Journal of Hematology 85:9, pages 733-734.
Crossref
Taimur Sher, Kena C. Miller, George Deeb, Kelvin Lee & Asher Chanan-Khan. (2010) Plasma cell leukaemia and other aggressive plasma cell malignancies. British Journal of Haematology 150:4, pages 418-427.
Crossref
Giridharan Ramsingh, Paul Mehan, Jingqin Luo, Ravi Vij & Daniel Morgensztern. (2009) Primary plasma cell leukemia. Cancer 115:24, pages 5734-5739.
Crossref
Attilio Olivieri, Immacolata Attolico, Michele Cimminiello, Giancarlo Discepoli & Rosa Anna Cifarelli. (2009) Lenalidomide can induce graft versus leukemia effect in primary plasma cell leukemia: A case report. Leukemia Research 33:11, pages e191-e193.
Crossref
Victor H. Jimenez-Zepeda & Virginia J. Dominguez-Martinez. (2009) Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis. International Journal of Hematology 89:3, pages 259-268.
Crossref
Pellegrino Musto, Giuseppe Pietrantuono, Roberto Guariglia, Oreste Villani, Maria Carmen Martorelli, Fiorella D’Auria, Antonia Zonno & Rosa Lerose. (2008) Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia. Leukemia Research 32:10, pages 1637-1638.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.